Sort
17,288 grants matching “multiple sclerosis”
INSULIN LIKE GROWTH FACTOR 1 ACTIONS IN OLIGODENDROCYTE
$261,714University Of North Carolina Chapel Hill · R01 · FY2002 · NS
Informatics Core
$261,606Daniel Scott Marcus · Washington University · P30 · FY2016 · NS
BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMA
$261,555Thomas Jefferson University · R01 · FY2000 · AR
BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMA
$261,555Thomas Jefferson University · R01 · FY2001 · AR
Cytokine regulation of glial reactivity
$261,522Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · NS
The regulation of myeloid cell development and mobilization during autoimmune dem
$261,498Benjamin Matthew Segal · University Of Michigan At Ann Arbor · R01 · FY2010 · NS
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTS
$261,314Texas A&M University System · R01 · FY2003 · GM
System for Automated Tracking of Leukocytes in Vivo
$261,161University Of Virginia Charlottesville · R33 · FY2004 · HL
Improving Learning in MS: A Randomized Clinical Trial
$261,129Nancy D. Chiaravalloti · Kessler Foundation, Inc. · R01 · FY2007 · HD
Core Facilities for Neurobiology at Brandeis
$261,013Michael Rosbash · Brandeis University · P30 · FY2010 · NS
TNF Family Members and Control of Fibrotic Disease
$261,000Michael Croft · La Jolla Institute For Immunology · R21 · FY2012 · AI
Mouse Model of Progressive Multifocal Leukoencephalopathy
$261,000Chen Sabrina Tan · Beth Israel Deaconess Medical Center · R21 · FY2015 · NS
ENGINEERING MANGANESE METALLOENZYMES
$260,971David W Christianson · University Of Pennsylvania · R01 · FY2009 · GM
Prostaglandin D2 Receptor Function
$260,818Richard M Breyer · Vanderbilt University · P50 · FY2009 · GM
Development of PET radiotracer for imaging sphingosine-1-phosphate receptor 2 (S1PR2)
$260,814Zhude Tu · Washington University · P41 · FY2024 · EB
Regulatory monocytes in CNS autoimmune disease
$260,807Scott S Zamvil · University Of California, San Francisco · R01 · FY2013 · NS
Project 2: Scleroderma-Associated Pulmonary Arterial Hypertension: The Role of the Oxidant State
$260,785Maria Trojanowska · University Of Pittsburgh At Pittsburgh · P50 · FY2020 · AR
PIVOTAL REGULATOR IN NEURO-IMMUNE INTERACTIONS
$260,750University Of Texas Medical Br Galveston · R01 · FY2002 · NS
PIVOTAL REGULATOR IN NEURO-IMMUNE INTERACTIONS
$260,750University Of Texas Medical Br Galveston · R01 · FY2001 · NS
Neurodevelopmental Behavioral Core
$260,584Michela Fagiolini · Boston Children'S Hospital · P30 · FY2012 · HD
Admixture-driven discovery of disease-associated genetic variants not found in Europeans
$260,360Adam Auton · 23andme, Inc. · R43 · FY2016 · HG
Targeting Jak3 in the treatment of autoimmune disease
$260,338John J. O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR
MAP3K8 in immunoregluation, host defense and autoimmunity
$260,338John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR
The Role of microRNAs in autoimmune disease
$260,335Lukas T. Jeker · University Hospital Basel · R01 · FY2016 · AI
MUCOSAL TOLERANCE IN AUTOIMMUNE ENCEPHALOMYELITIS
$260,317Ohio State University · R01 · FY2000 · AI